Functional significance of mononuclear Phagocyte populations generated through adult Hematopoiesis

Journal of Leukocyte Biology

Volumn 96, Issue 6, 2014, Pages 969-980

  Gutknecht, Michael F ^a   Bouton, Amy H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

MDSC; Monocyte differentiation; Tumor microenvironment

Indexed keywords

CD11B ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; NUCLEAR RECEPTOR NUR77; ORPHAN NUCLEAR RECEPTOR; PROTEIN TYROSINE KINASE; TOLL LIKE RECEPTOR 7; TRANSCRIPTION FACTOR MAFB; TRANSCRIPTION FACTOR PU 1; CHEMOKINE RECEPTOR; COLONY STIMULATING FACTOR 1; CX3CR1 PROTEIN, MOUSE; CYTOKINE; LY ANTIGEN; LY-6C ANTIGEN, MOUSE; TRANSCRIPTION FACTOR;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CANCER CONTROL; CANCER STAGING; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MOTILITY; CELL POPULATION; CELL PROLIFERATION; DENDRITIC CELL; DISEASE COURSE; EMBRYO DEVELOPMENT; GRANULOCYTE; HEMATOPOIESIS; HUMAN; INTRACELLULAR SIGNALING; METASTASIS; MONONUCLEAR PHAGOCYTE; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; SOLID TUMOR; TH2 CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIUM; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; CELL LINEAGE; CELL MOTION; CLASSIFICATION; CYTOLOGY; EMBRYOLOGY; GENE EXPRESSION REGULATION; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MONOCYTE; MOUSE; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALS; ANTIGENS, LY; CELL LINEAGE; CELL MOVEMENT; CYTOKINES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; MODELS, BIOLOGICAL; MONOCYTES; NEOPLASM METASTASIS; NEOPLASMS; ORGAN SPECIFICITY; RECEPTORS, CHEMOKINE; TRANSCRIPTION FACTORS; TUMOR MICROENVIRONMENT;

EID: 84914170224     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.1RI0414-195R     Document Type: Article

References (153)

1. Hoffmann, J. A., Kafatos, F. C., Janeway, C. A., Ezekowitz, R. A. (1999) Phylogenetic perspectives in innate immunity. Science 284, 1313-1318.
2. Gordon, S., Taylor, P. R. (2005) Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5, 953-964.
3. Gordon, S. (2007) The macrophage: past, present and future. Eur. Immunol. 37 (Suppl. 1), S9-S17.
4. Wynn, T. A., Chawla, A., Pollard, J. W. (2013) Macrophage biology in development, homeostasis and disease. Nature 496, 445-455.
5. Murray, P. J., Wynn, T. A. (2011) Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11, 723-737.
6. Pollard, J. W. (2009) Trophic macrophages in development and disease. Nat. Rev. Immunol. 9, 259-270.
7. Hume, D. A. (2006) The mononuclear phagocyte system. Curr. Opin. Immunol. 18, 49-53.
8. Hume, D. A. (2008) Differentiation and heterogeneity in the mononuclear phagocyte system. Mucosal Immunol. 1, 432-441.
9. Ginhoux, F., Jung, S. (2014) Monocytes and macrophages: developmental pathways and tissue homeostasis. Nat. Rev. Immunol. 14, 392-404.
10. Schulz, C., Gomez Perdiguero, E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E., Pollard, J. W., Frampton, J., Liu, K. J., Geissmann, F. (2012) A lineage of myeloid cells independent of myb and hematopoietic stem cells. Science 336, 86-90.
11. Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., Samokhvalov, I. M., Merad, M. (2010) Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841-845.
12. Hoeffel, G., Wang, Y., Greter, M., See, P., Teo, P., Malleret, B., Leboeuf, M., Low, D., Oller, G., Almeida, F., Choy, S. H., Grisotto, M., Renia, L., Conway, S. J., Stanley, E. R., Chan, J. K., Ng, L. G., Samokhvalov, I. M., Merad, M., Ginhoux, F. (2012) Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 209, 1167-1181.
13. Sieweke, M. H., Allen, J. E. (2013) Beyond stem cells: self-renewal of differentiated macrophages. Science 342, 1242974.
14. Davies, L. C., Jenkins, S. J., Allen, J. E., Taylor, P. R. (2013) Tissue-resident macrophages. Nat. Immunol. 14, 986-995.
15. Van Furth, R., Cohn, Z. A. (1968) The origin and kinetics of mononuclear phagocytes. J. Exp. Med. 128, 415-435.
16. Takahashi, K. (2001) Development and differentiation of macrophages and related cells; historical review and current concepts. J. Clin. Expt. Hematophath. 41, 1-33.
17. Hashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., Greter, M., Mortha, A., Boyer, S. W., Forsberg, E. C., Tanaka, M., van Rooijen, N., Garcia-Sastre, A., Stanley, E. R., Ginhoux, F., Frenette, P. S., Merad, M. (2013) Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792-804.
18. Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., Rossi, F. M. (2007) Local self-renewal can sustain CNS microglia maintenance and function throughout adult life. Nat. Neurosci. 10, 1538-1543.
19. Hume, D. A., Ross, I. L., Himes, S. R., Sasmono, R. T., Wells, C. A., Ravasi, T. (2002) The mononuclear phagocyte system revisited. J. Leukoc. Biol. 72, 621-627.
20. Iwasaki, H., Akashi, K. (2007) Myeloid lineage commitment from the hematopoietic stem cell. Immunity 26, 726-740.
21. Enver, T., Pera, M., Peterson, C., Andrews, P. W. (2009) Stem cell states, fates, and the rules of attraction. Cell. Stem Cell 4, 387-397.
22. Orkin, S. H., Zon, L. I. (2008) Hematopoiesis: an evolving paradigm for stem cell biology. Cell 132, 631-644.
23. Valledor, A. F., Borras, F. E., Cullell-Young, M., Celada, A. (1998) Transcription factors that regulate monocyte/macrophage differentiation. J. Leukoc. Biol. 63, 405-417.
24. Lenny, N., Westendorf, J. J., Hiebert, S. W. (1997) Transcriptional regulation during myelopoiesis. Mol. Biol. Rep. 24, 157-168.
25. Akashi, K., Traver, D., Miyamoto, T., Weissman, I. L. (2000) A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404, 193-197.
26. Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano, A., Geissmann, F. (2006) A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 311, 83-87.
27. Stanley, E. R., Berg, K. L., Einstein, D. B., Lee, P. S., Pixley, F. J., Wang, Y., Yeung, Y. G. (1997) Biology and action of colony-stimulating factor-1. Mol. Reproduc. Dev. 46, 4-10.
28. Stanley, E. R., Chitu, V. (2014) CSF-1 receptor signaling in myeloid cells. Cold Spring Harb. Perspect. Biol. 6, pii: a021857.
29. Mossadegh-Keller, N., Sarrazin, S., Kandalla, P. K., Espinosa, L., Stanley, E. R., Nutt, S. L., Moore, Sieweke, J., H. (2013) M-CSF instructs myeloid lineage fate in single haematopoietic stem cells. Nature 497, 239-243.
30. McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J., Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., Maki, R. A. (1996) Targeted disruption of the PU. 1 gene results in multiple hematopoietic abnormalities. EMBO J. 15, 5647-5658.
31. DeKoter, R. P., Walsh, J. C., Singh, H. (1998) PU. 1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17, 4456-4468.
32. Nerlov, C., Graf, T. (1998) PU. 1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12, 2403-2412.
33. Sarrazin, S., Mossadegh-Keller, N., Fukao, T., Aziz, A., Mourcin, F., Vanhille, L., Kelly Modis, L., Kastner, P., Chan, S., Duprez, E., Otto, C., Sieweke, M. H. (2009) MafB restricts M-CSF-dependent myeloid commitment divisions of hematopoietic stem cells. Cell 138, 300-313.
34. Rieger, M. A., Hoppe, P. S., Smejkal, B. M., Eitelhuber, A. C., Schroeder, T. (2009) Hematopoietic cytokines can instruct lineage choice. Science 325, 217-218.
35. Stanley, E. R. (2009) Lineage commitment: cytokines instruct, at last! Cell. Stem Cell 5, 234-236.
36. Nutt, S. L., Busslinger, M. (1999) Monoallelic expression of Pax5: a paradigm for the haploinsufficiency of mammalian Pax genes? Biol. Chem. 380, 601-611.
37. Orkin, S. H. (2000) Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1, 57-64.
38. Cantor, A. B., Orkin, S. H. (2001) Hematopoietic development: a balancing act. Cur. Opin. Genet. Dev. 11, 513-519.
39. Hettinger, J., Richards, D. M., Hansson, J., Barra, M. M., Joschko, A. C., Krijgsveld, J., Feuerer, M. (2013) Origin of monocytes and macrophages in a committed progenitor. Nat. Immunol. 14, 821-830.
40. Terry, R. L., Miller, S. D. (2014) Molecular control of monocyte development. Cell. Immunol. doi: 10.1016/j.cellimm.2014.02.008 [Epub ahead of print].
41. Geissmann, F., Jung, S., Littman, D. R. (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82.
42. Shi, C., Sakuma, M., Mooroka, T., Liscoe, A., Gao, H., Croce, K. J., Sharma, A., Kaplan, D., Greaves, D. R., Wang, Y., Simon, D. I. (2008) Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood 112, 4699-4711.
43. Leenen, P. J., de Bruijn, M. F., Voerman, J. S., Campbell, P. A., van Ewijk, W. (1994) Markers of mouse macrophage development detected by monoclonal antibodies. J. Immunol. Methods 174, 5-19.
44. Jutila, M. A., Kroese, F. G., Jutila, K. L., Stall, A. M., Fiering, S., Herzenberg, L. A., Berg, E. L., Butcher, E. C. (1988) Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur. J. Immunol. 18, 1819-1826.
45. Landsman, L., Bar-On, L., Zernecke, A., Kim, K. W., Krauthgamer, R., Shagdarsuren, E., Lira, S. A., Weissman, I. L., Weber, C., Jung, S. (2009) CX3CR1 is required for monocyte homeostasis and atherogenesis by promoting cell survival. Blood 113, 963-972.
46. Goda, S., Imai, T., Yoshie, O., Yoneda, O., Inoue, H., Nagano, Y., Okazaki, T., Imai, H., Bloom, E. T., Domae, N., Umehara, H. (2000) CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and-independent mechanisms. J. Immunol. 164, 4313-4320.
47. Fong, A. M., Robinson, L. A., Steeber, D. A., Tedder, T. F., Yoshie, O., Imai, T., Patel, D. D. (1998) Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J. Exp. Med. 188, 1413-1419.
48. Cambien, B., Pomeranz, M., Millet, M. A., Rossi, B., Schmid-Alliana, A. (2001) Signal transduction involved in MCP-1-mediated monocytic transendothelial migration. Blood 97, 359-366.
49. Imhof, B. A., Aurrand-Lions, M. (2004) Adhesion mechanisms regulating the migration of monocytes. Nat. Rev. Immunol. 4, 432-444.
50. Kamei, M., Carman, C. V. (2010) New observations on the trafficking and diapedesis of monocytes. Cur. Opin. Hematol. 17, 43-52.
51. Tsou, C. L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., Charo, I. F. (2007) Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J. Clin. Investig. 117, 902-909.
52. Auffray, C., Sieweke, M. H., Geissmann, F. (2009) Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27, 669-692.
53. Xu, H., Manivannan, A., Crane, I., Dawson, R., Liversidge, J. (2008) Critical but divergent roles for CD62L and CD44 in directing blood monocyte trafficking in vivo during inflammation. Blood 112, 1166-1174.
54. Luscinskas, F. W., Kansas, G. S., Ding, H., Pizcueta, P., Schleiffenbaum, B. E., Tedder, T. F., Gimbrone M. A., Jr., (1994) Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J. Cell Biol. 125, 1417-1427.
55. Giuffre, L., Cordey, A. S., Monai, N., Tardy, Y., Schapira, M., Spertini, O. (1997) Monocyte adhesion to activated aortic endothelium: role of L-selectin and heparan sulfate proteoglycans. J. Cell Biol. 136, 945-956.
56. Ley, K. (2003) The role of selectins in inflammation and disease. Trends Mol. Med. 9, 263-268.
57. Imai, T., Hieshima, K., Haskell, C., Baba, M., Nagira, M., Nishimura, M., Kakizaki, M., Takagi, S., Nomiyama, H., Schall, T. J., Yoshie, O. (1997) Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91, 521-530.
58. Hanninen, A., Jaakkola, I., Salmi, M., Simell, O., Jalkanen, S. (1997) Ly-6C regulates endothelial adhesion and homing of CD8(+) T cells by activating integrin-dependent adhesion pathways. Proc. Natl. Acad. Sci. USA 94, 6898-6903.
59. Chiossone, L., Chaix, J., Fuseri, N., Roth, C., Vivier, E., Walzer, T. (2009) Maturation of mouse NK cells is a 4-stage developmental program. Blood 113, 5488-5496.
60. Ding, C., Ma, Y., Chen, X., Liu, M., Cai, Y., Hu, X., Xiang, D., Nath, S., Zhang, H. G., Ye, H., Powell, D., Yan, J. (2013) Integrin CD11b negatively regulates BCR signalling to maintain autoreactive B cell tolerance. Nat. Commun. 4, 2813.
61. Leenen, P. J., Melis, M., Slieker, W. A., Van Ewijk, W. (1990) Murine macrophage precursor characterization. II. Monoclonal antibodies against macrophage precursor antigens. Eur. J. Immunol. 20, 27-34.
62. Sunderkotter, C., Nikolic, T., Dillon, M. J., Van Rooijen, N., Stehling, M., Drevets, D. A., Leenen, P. J. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172, 4410-4417.
63. Varol, C., Yona, S., Jung, S. (2009) Origins and tissue-context-dependent fates of blood monocytes. Immunol. Cell Biol. 87, 30-38.
64. Yona, S., Kim, K. W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., Hume, D. A., Perlman, H., Malissen, B., Zelzer, E., Jung, S. (2013) Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79-91.
65. MacDonald, K. P., Palmer, J. S., Cronau, S., Seppanen, E., Olver, S., Raffelt, N. C., Kuns, R., Pettit, A. R., Clouston, A., Wainwright, B., Branstetter, D., Smith, J., Paxton, R. J., Cerretti, D. P., Bonham, L., Hill, G. R., Hume, D. A. (2010) An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissueand tumor-associated macrophages but does not inhibit inflammation. Blood 116, 3955-3963.
66. Bartocci, A., Mastrogiannis, D. S., Migliorati, G., Stockert, R. J., Wolkoff, A. W., Stanley, E. R. (1987) Macrophages specifically regulate the concentration of their own growth factor in the circulation. Proc. Natl. Acad. Sci. USA 84, 6179-6183.
67. Ingersoll, M. A., Spanbroek, R., Lottaz, C., Gautier, E. L., Frankenberger, M., Hoffmann, R., Lang, R., Haniffa, M., Collin, M., Tacke, F., Habenicht, A. J., Ziegler-Heitbrock, L., Randolph, G. J. (2010) Comparison of gene expression profiles between human and mouse monocyte subsets. Blood 115, e10-e19.
68. Shi, C., Pamer, E. G. (2011) Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11, 762-774.
69. Beekhuizen, H., van Furth, R. (1993) Monocyte adherence to human vascular endothelium. J. Leukoc. Biol. 54, 363-378.
70. Spertini, O., Cordey, A. S., Monai, N., Giuffre, L., Schapira, M. (1996) P-Selectin glycoprotein ligand 1 is a ligand for L-selectin on neutrophils, monocytes, and CD34_hematopoietic progenitor cells. J. Cell Biol. 135, 523-531.
71. Laudanna, C., Kim, J. Y., Constantin, G., Butcher, E. (2002) Rapid leukocyte integrin activation by chemokines. Immunol. Rev. 186, 37-46.
72. Herter, J., Zarbock, A. (2013) Integrin regulation during leukocyte recruitment. J. Immunol. 190, 4451-4457.
73. Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., Geissmann, F. (2007) Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670.
74. Sumagin, R., Prizant, H., Lomakina, E., Waugh, R. E., Sarelius, I. H. (2010) LFA-1 and MAC-1 define characteristically different intralumenal crawling and emigration patterns for monocytes and neutrophils in situ. J. Immunol. 185, 7057-7066.
75. Carlin, L. M., Stamatiades, E. G., Auffray, C., Hanna, R. N., Glover, L., Vizcay-Barrena, G., Hedrick, C. C., Cook, H. T., Diebold, S., Geissmann, F. (2013) Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells and orchestrate their disposal. Cell 153, 362-375.
76. Jakubzick, C., Gautier, E. L., Gibbings, S. L., Sojka, D. K., Schlitzer, A., Johnson, T. E., Ivanov, S., Duan, Q., Bala, S., Condon, T., van Rooijen, N., Grainger, J. R., Belkaid, Y., Ma’ayan, A., Riches, D. W., Yokoyama, W. M., Ginhoux, F., Henson, P. M., Randolph, G. J. (2013) Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 39, 599-610.
77. Landsman, L., Varol, C., Jung, S. (2007) Distinct differentiation potential of blood monocyte subsets in the lung. J. Immunol. 178, 2000-2007.
78. Lin, S. L., Castano, A. P., Nowlin, B. T., Lupher M. L., Jr., Duffield, J. S. (2009) Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J. Immunol. 183, 6733-6743.
79. Nahrendorf, M., Swirski, F. K. (2013) Monocyte and macrophage heterogeneity in the heart. Circ. Res. 112, 1624-1633.
80. Ley, K., Miller, Y. I., Hedrick, C. C. (2011) Monocyte and macrophage dynamics during atherogenesis. Arterioscler. Thromb. Vasc. Biol. 31, 1506-1516.
81. Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J. L., Libby, P., Weissleder, R., Pittet, M. J. (2007) The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047.
82. Frantz, S., Nahrendorf, M. (2014) Cardiac macrophages and their role in ischaemic heart disease. Cardiovasc. Res. 102, 240-248.
83. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
84. Biswas, S. K., Mantovani, A. (2010) Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 11, 889-896.
85. Sica, A., Mantovani, A. (2012) Macrophage plasticity and polarization: in vivo veritas. J. Clin. Investig. 122, 787-795.
86. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. Hill, M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
87. Martinez, F. O., Gordon, S. (2014) The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6, 13.
88. Barreda, D. R., Hanington, P. C., Belosevic, M. (2004) Regulation of myeloid development and function by colony stimulating factors. Dev. Comp. Immunol. 28, 509-554.
89. Hamilton, J. A. (2008) Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8, 533-544.
90. Pixley, F. J., Stanley, E. R. (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628-638.
91. Yu, W., Chen, J., Xiong, Y., Pixley, F. J., Yeung, Y. G., Stanley, E. R. (2012) Macrophage proliferation is regulated through CSF-1 receptor tyrosines 544, 559, and 807. J. Biol. Chem. 287, 13694-13704.
92. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante A. W., Jr., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., Stanley, E. R. (1990) Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 87, 4828-4832.
93. Dai, X. M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., Stanley, E. R. (2002) Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood 99, 111-120.
94. Lin, H., Lee, E., Hestir, K., Leo, C., Huang, M., Bosch, E., Halenbeck, R., Wu, G., Zhou, A., Behrens, D., Hollenbaugh, D., Linnemann, T., Qin, M., Wong, J., Chu, K., Doberstein, S. K., Williams, L. T. (2008) Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807-811.
95. Wei, S., Nandi, S., Chitu, V., Yeung, Y. G., Yu, W., Huang, M., Williams, L. T., Lin, H., Stanley, E. R. (2010) Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J. Leukoc. Biol. 88, 495-505.
96. Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., Colonna, M. (2012) IL-34 is a tissuerestricted ligand of CSF1R required for the development of Langerhans cells and microglia. Nat. Immunol. 13, 753-760.
97. Nandi, S., Gokhan, S., Dai, X. M., Wei, S., Enikolopov, G., Lin, H., Mehler, M. F., Stanley, E. R. (2012) The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Develop. Biol. 367, 100-113.
98. Sasmono, R. T., Oceandy, D., Pollard, J. W., Tong, W., Pavli, P., Wainwright, B. J., Ostrowski, M. C., Himes, S. R., Hume, D. A. (2003) A macrophage colony-stimulating factor receptor-green fluorescent protein transgene is expressed throughout the mononuclear phagocyte system of the mouse. Blood 101, 1155-1163.
99. Austyn, J. M., Gordon, S. (1981) F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol. 11, 805-815.
100. Burgess, A. W., Metcalf, D. (1980) The nature and action of granulocyte-macrophage colony stimulating factors. Blood 56, 947-958.
101. Hamilton, J. A. (2002) GM-CSF in inflammation and autoimmunity. Trends Immunol. 23, 403-408.
102. Stanley, E., Lieschke, G. J., Grail, D., Metcalf, D., Hodgson, G., Gall, J. A., Maher, D. W., Cebon, J., Sinickas, V., Dunn, A. R. (1994) Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91, 5592-5596.
103. Lenzo, J. C., Turner, A. L., Cook, A. D., Vlahos, R., Anderson, G. P., Reynolds, E. C., Hamilton, J. A. (2012) Control of macrophage lineage populations by CSF-1 receptor and GM-CSF in homeostasis and inflammation. Immunol. Cell Biol. 90, 429-440.
104. Hamilton, J. A., Achuthan, A. (2013) Colony stimulating factors and myeloid cell biology in health and disease. Trends Immunol. 34, 81-89.
105. Fleetwood, A. J., Lawrence, T., Hamilton, J. A., Cook, A. D. (2007) Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF blockade in inflammation. J. Immunol. 178, 5245-5252.
106. Hanna, R. N., Carlin, L. M., Hubbeling, H. G., Nackiewicz, D., Green, A. M., Punt, J. A., Geissmann, F., Hedrick, C. C. (2011) The transcription factor Nr4a1 (Nur77) controls bone marrow differentiation and the survival of Ly6C-monocytes. Nat. Immunol. 12, 778-785.
107. Cain, D. W., Gunn, M. D. (2011) Nur who? An orphan transcription factor holds promise for monomaniacs. Nat. Immunol. 12, 727-729.
108. Laoui, D., Van Overmeire, E., Movahedi, K., Van den Bossche, J., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., De Baetselier, P., Van Ginderachter, J. A. (2011) Mononuclear phagocyte heterogeneity in cancer: different subsets and activation states reaching out at the tumor site. Immunobiology 216, 1192-1202.
109. Chioda, M., Peranzoni, E., Desantis, G., Papalini, F., Falisi, E., Solito, S., Mandruzzato, S., Bronte, V. (2011) Myeloid cell diversification and complexity: an old concept with new turns in oncology. Cancer Metastasis Rev. 30, 27-43.
110. Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., Condeelis, J. (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029.
111. Goswami, S., Sahai, E., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., Condeelis, J. S. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65, 5278-5283.
112. Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schafer, R., Stanley, E. R., Abraham, D. (2004) Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 64, 5378-5384.
113. Aharinejad, S., Abraham, D., Paulus, P., Abri, H., Hofmann, M., Grossschmidt, K., Schafer, R., Stanley, E. R., Hofbauer, R. (2002) Colonystimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 62, 5317-5324.
114. Robinson, B. D., Sica, G. L., Liu, Y. F., Rohan, T. E., Gertler, F. B., Condeelis, J. S., Jones, J. G. (2009) Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin. Cancer Res. 15, 2433-2441.
115. Balkwill, F. (2004) Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
116. Gabrilovich, D. I., Ostrand-Rosenberg, S., Bronte, V. (2012) Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12, 253-268.
117. Sica, A., Bronte, V. (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Investig. 117, 1155-1166.
118. Bingle, L., Brown, N. J., Lewis, C. E. (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265.
119. Diaz-Montero, C. M., Salem, M. L., Nishimura, M. I., Garrett-Mayer, E., Cole, D. J., Montero, A. J. (2009) Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunol. Immunother. 58, 49-59.
120. Allavena, P., Sica, A., Solinas, G., Porta, C., Mantovani, A. (2008) The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit. Rev. Oncol. Hematol. 66, 1-9.
121. Pollard, J. W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78.
122. Qian, B. Z., Pollard, J. W. (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39-51.
123. Roussos, E. T., Balsamo, M., Alford, S. K., Wyckoff, J. B., Gligorijevic, B., Wang, Y., Pozzuto, M., Stobezki, R., Goswami, S., Segall, J. E., Lauffenburger, D. A., Bresnick, A. R., Gertler, F. B., Condeelis, J. S. (2011) Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer J. Cell Sci. 124, 2120-2131.
124. Lin, E. Y., Li, J. F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X. N., Pollard, J. W. (2006) Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66, 11238-11246.
125. Mantovani, A., Sica, A., Locati, M. (2005) Macrophage polarization comes of age. Immunity 23, 344-346.
126. Martinez, F. O., Gordon, S., Locati, M., Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311.
127. Mosser, D. M., Edwards, J. P. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969.
128. Fonsatti, E., Maio, M., Altomonte, M., Hersey, P. (2010) Biology and clinical applications of CD40 in cancer treatment. Seminars Oncol. 37, 517-523.
129. Beatty, G. L., Chiorean, E. G., Fishman, M. P., Saboury, B., Teitelbaum, U. R., Sun, W., Huhn, R. D., Song, W., Li, D., Sharp, L. L., Torigian, D. A., O’Dwyer, P. J., Vonderheide, R. H. (2011) CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 331, 1612-1616.
130. Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., Setty, M., Leslie, C. S., Oei, Y., Pedraza, A., Zhang, J., Brennan, C. W., Sutton, J. C., Holland, E. C., Daniel, D., Joyce, J. A. (2013) CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264-1272.
131. Ahn, G. O., Tseng, D., Liao, C. H., Dorie, M. J., Czechowicz, A., Brown, J. M. (2010) Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc. Natl. Acad. Sci. USA 107, 8363-8368.
132. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., Gabrilovich, D. I. (2001) Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol. 166, 678-689.
133. Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P., Zanovello, P. (2000) Identification of a CD11b(+)/GR-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells. Blood 96, 3838-3846.
134. Mosmann, T. R., Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
135. Kusmartsev, S., Gabrilovich, D. I. (2002) Immature myeloid cells and cancer-associated immune suppression. Cancer Immunol. Immunother. 51, 293-298.
136. Gabrilovich, D. I., Nagaraj, S. (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9, 162-174.
137. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Geilich, M., Winkels, G., Traggiai, E., Casati, A., Grassi, F., Bronte, V. (2010) Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur. J. Immunol. 40, 22-35.
138. Youn, J. I., Nagaraj, S., Collazo, M., Gabrilovich, D. I. (2008) Subsets of myeloid-derived suppressor cells in tumor-bearing mice. J. Immunol. 181, 5791-5802.
139. Youn, J. I., Gabrilovich, D. I. (2010) The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur. J. Immunol. 40, 2969-2975.
140. Ozao-Choy, J., Ma, G., Kao, J., Wang, G. X., Meseck, M., Sung, M., Schwartz, M., Divino, C. M., Pan, P. Y., Chen, S. H. (2009) The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. Cancer Res. 69, 2514-2522.
141. Augier, S., Ciucci, T., Luci, C., Carle, G. F., Blin-Wakkach, C., Wakkach, A. (2010) Inflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillance. J. Immunol. 185, 7165-7173.
142. Pommier, A., Audemard, A., Durand, A., Lengagne, R., Delpoux, A., Martin, B., Douguet, L., Le Campion, A., Kato, M., Avril, M. F., Auffray, C., Lucas, B., Prevost-Blondel, A. (2013) Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+T cells. Proc. Natl. Acad. Sci. USA 110, 13085-13090.
143. Sanford, D. E., Belt, B. A., Panni, R. Z., Mayer, A., Deshpande, A. D., Carpenter, D., Mitchem, J. B., Plambeck-Suess, S. M., Worley, L. A., Goetz, B. D., Wang-Gillam, A., Eberlein, T. J., Denardo, D. G., Goedegebuure, S. P., Linehan, D. C. (2013) Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis. Clin. Cancer Res. 19, 3404-3415.
144. Kusmartsev, S., Gabrilovich, D. I. (2005) STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174, 4880-4891.
145. Van Ginderachter, J. A., Meerschaut, S., Liu, Y., Brys, L., De Groeve, K., Hassanzadeh Ghassabeh, G., Raes, G., De Baetselier, P. (2006) Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands reverse CTL suppression by alternatively activated (M2) macrophages in cancer. Blood 108, 525-535.
146. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008) Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity. Blood 111, 4233-4244.
147. Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis, E., Quiceno, D. G., Padhya, T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2010) HIF-1alpha regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J. Exp. Med. 207, 2439-2453.
148. Ma, G., Pan, P. Y., Eisenstein, S., Divino, C. M., Lowell, C. A., Takai, T., Chen, S. H. (2011) Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 34, 385-395.
149. Movahedi, K., Laoui, D., Gysemans, C., Baeten, M., Stange, G., Van den Bossche, J., Mack, M., Pipeleers, D., In’t Veld, P., De Baetselier, P., Van Ginderachter, J. A. (2010) Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 70, 5728-5739.
150. De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L., Lewis, C. E. (2007) Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28, 519-524.
151. De Palma, M., Venneri, M. A., Galli, R., Sergi Sergi, L., Politi, L. S., Sampaolesi, M., Naldini, L. (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8, 211-226.
152. Pucci, F., Venneri, M. A., Biziato, D., Nonis, A., Moi, D., Sica, A., Di Serio, C., Naldini, L., De Palma, M. (2009) A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood 114, 901-914.
153. Chow, A., Brown, B. D., Merad, M. (2011) Studying the mononuclear phagocyte system in the molecular age. Nat. Rev. Immunol. 11, 788-798.